| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |